A private investment group founded by a wealthy family has operation in China and the US. The group is actively seeking new investments in the life sciences across the US, and it occasionally invests in companies in Europe. The group focuses on pre-clinical and clinical stage companies. The investment size will vary and typically it ranges from $2 million -$10 million. The group has no set number of allocations over the next 6-9 months.
In the life sciences, the firm is looking for new investments in the biotech therapeutics sector. The group will also consider investing in medical devices and diagnostics opportunities, however that is not their main focus area. The firm is open to both 510K and PMA medical devices. For therapeutics, the group is most interested in biologics. The group invests in a variety of therapeutic areas with a focus on oncology. The group generally invests in pre-clinical stage companies without clinical data, and it also syndicates with other investors for clinical-stage investments.
The firm invests in privately-held life science companies. The group is generally not interested in commercial-stage companies.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com
Next Phase Newsletter 
Leave a comment